These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10090743)

  • 1. Recognition sequence design for peptidyl modulators of beta-amyloid aggregation and toxicity.
    Pallitto MM; Ghanta J; Heinzelman P; Kiessling LL; Murphy RM
    Biochemistry; 1999 Mar; 38(12):3570-8. PubMed ID: 10090743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of peptidyl compounds that affect beta-amyloid aggregation: importance of surface tension and context.
    Gibson TJ; Murphy RM
    Biochemistry; 2005 Jun; 44(24):8898-907. PubMed ID: 15952797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designing peptide inhibitors for oligomerization and toxicity of Alzheimer's beta-amyloid peptide.
    Austen BM; Paleologou KE; Ali SA; Qureshi MM; Allsop D; El-Agnaf OM
    Biochemistry; 2008 Feb; 47(7):1984-92. PubMed ID: 18189413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-function relationships for inhibitors of beta-amyloid toxicity containing the recognition sequence KLVFF.
    Lowe TL; Strzelec A; Kiessling LL; Murphy RM
    Biochemistry; 2001 Jul; 40(26):7882-9. PubMed ID: 11425316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid peptides attenuate cytotoxicity of beta-amyloid by inhibiting its oligomerization: implication from solvent effects.
    Sun X; Wu WH; Liu Q; Chen MS; Yu YP; Ma Y; Zhao YF; Li YM
    Peptides; 2009 Jul; 30(7):1282-7. PubMed ID: 19397942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Branched KLVFF tetramers strongly potentiate inhibition of beta-amyloid aggregation.
    Chafekar SM; Malda H; Merkx M; Meijer EW; Viertl D; Lashuel HA; Baas F; Scheper W
    Chembiochem; 2007 Oct; 8(15):1857-64. PubMed ID: 17763487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide inhibitors of beta-amyloid aggregation.
    Doig AJ
    Curr Opin Drug Discov Devel; 2007 Sep; 10(5):533-9. PubMed ID: 17786851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assembling amyloid fibrils from designed structures containing a significant amyloid beta-peptide fragment.
    Tjernberg LO; Tjernberg A; Bark N; Shi Y; Ruzsicska BP; Bu Z; Thyberg J; Callaway DJ
    Biochem J; 2002 Aug; 366(Pt 1):343-51. PubMed ID: 12023906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of aggregation inhibitors for amyloid-beta peptides and their evaluation by quartz-crystal microbalance.
    Okuno H; Mori K; Okada T; Yokoyama Y; Suzuki H
    Chem Biol Drug Des; 2007 May; 69(5):356-61. PubMed ID: 17539828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of protein aggregation and toxicity.
    Amijee H; Madine J; Middleton DA; Doig AJ
    Biochem Soc Trans; 2009 Aug; 37(Pt 4):692-6. PubMed ID: 19614577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationally designed dehydroalanine (DeltaAla)-containing peptides inhibit amyloid-beta (Abeta) peptide aggregation.
    Rangachari V; Davey ZS; Healy B; Moore BD; Sonoda LK; Cusack B; Maharvi GM; Fauq AH; Rosenberry TL
    Biopolymers; 2009 Jun; 91(6):456-65. PubMed ID: 19189374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stoichiometric inhibition of amyloid beta-protein aggregation with peptides containing alternating alpha,alpha-disubstituted amino acids.
    Etienne MA; Aucoin JP; Fu Y; McCarley RL; Hammer RP
    J Am Chem Soc; 2006 Mar; 128(11):3522-3. PubMed ID: 16536517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phage display affords peptides that modulate beta-amyloid aggregation.
    Orner BP; Liu L; Murphy RM; Kiessling LL
    J Am Chem Soc; 2006 Sep; 128(36):11882-9. PubMed ID: 16953628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of colostrinin on neuroblastoma cell survival is due to reduced aggregation of beta-amyloid.
    Schuster D; Rajendran A; Hui SW; Nicotera T; Srikrishnan T; Kruzel ML
    Neuropeptides; 2005 Aug; 39(4):419-26. PubMed ID: 15890402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity.
    Wilhelmus MM; Boelens WC; Otte-Höller I; Kamps B; de Waal RM; Verbeek MM
    Brain Res; 2006 May; 1089(1):67-78. PubMed ID: 16635482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of clicked curcumin and clicked KLVFFA conjugates as inhibitors of beta-amyloid fibril formation.
    Ouberai M; Dumy P; Chierici S; Garcia J
    Bioconjug Chem; 2009 Nov; 20(11):2123-32. PubMed ID: 19821579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting in vivo effects of two peptide-based amyloid-beta protein aggregation inhibitors in a transgenic mouse model of amyloid deposition.
    Li Q; Gordon M; Etienne MA; Hammer RP; Morgan D
    Cell Transplant; 2008; 17(4):397-408. PubMed ID: 18522242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's Abeta peptides containing an isostructural backbone mutation afford distinct aggregate morphologies but analogous cytotoxicity. Evidence for a common low-abundance toxic structure(s)?
    Bieschke J; Siegel SJ; Fu Y; Kelly JW
    Biochemistry; 2008 Jan; 47(1):50-9. PubMed ID: 18078350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human apolipoprotein A-I binds amyloid-beta and prevents Abeta-induced neurotoxicity.
    Paula-Lima AC; Tricerri MA; Brito-Moreira J; Bomfim TR; Oliveira FF; Magdesian MH; Grinberg LT; Panizzutti R; Ferreira ST
    Int J Biochem Cell Biol; 2009 Jun; 41(6):1361-70. PubMed ID: 19130896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.